Nektar Therapeutics (NKTR) AGM 2026 summary

Opening remarks and agenda

• Meeting opened by Vice President, Legal and Corporate Counsel, with board members, executive team, and auditors present.

• Formal business included voting on four proposals, followed by business highlights and a Q&A session.

Shareholder proposals

• Four proposals: election of one director, amendment to increase shares in the 2017 Performance Incentive Plan, ratification of auditors, and a non-binding advisory vote on executive compensation.

Overview of voting outcomes

• All four proposals were approved by a majority of shares voted, including director election, plan amendment, auditor ratification, and executive compensation.

• Final results to be published in a Form 8-K within four business days.